These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15585479)

  • 1. 99mTc-exametazime as a breast tumor-seeking agent: comparison with 99mTc-sestamibi.
    Wilczek B; Svensson L; Danielsson R; Celebiouglu F; Larsson SA; Jacobsson H
    J Nucl Med; 2004 Dec; 45(12):2040-4. PubMed ID: 15585479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 99mTc-sestamibi imaging in the assessment of toremifene as a modulator of multidrug resistance in patients with breast cancer.
    Mubashar M; Harrington KJ; Chaudhary KS; Lalani el-N; Stamp GW; Sinnett D; Glass DM; Peters AM
    J Nucl Med; 2002 Apr; 43(4):519-25. PubMed ID: 11937596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technetium-99m-sestamibi uptake by human benign and malignant breast tumor cells: correlation with mdr gene expression.
    Cordobes MD; Starzec A; Delmon-Moingeon L; Blanchot C; Kouyoumdjian JC; Prévost G; Caglar M; Moretti JL
    J Nucl Med; 1996 Feb; 37(2):286-9. PubMed ID: 8667063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between 99mTc-MIBI uptake and angiogenesis in MIBI-positive breast lesions.
    Bekiş R; Degirmenci B; Aydin A; Ozdogan O; Canda T; Durak H
    Nucl Med Biol; 2005 Jul; 32(5):465-72. PubMed ID: 15982577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 99mTc-sestamibi uptake and histological malignancy grade in invasive breast carcinoma.
    Danielsson R; Sánchez-Crespo A; Pegerfalk A; Grabowska H; Larsson SA; Boné B; Aspelin P
    Eur J Nucl Med Mol Imaging; 2003 May; 30(5):662-6. PubMed ID: 12616323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of asiaticoside on 99mTc-tetrofosmin and 99mTc-sestamibi uptake in MCF-7 cells.
    Al-Saeedi FJ; Bitar M; Pariyani S
    J Nucl Med Technol; 2011 Dec; 39(4):279-83. PubMed ID: 22080437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of (99m)Tc-sestamibi washout in predicting response of locally advanced breast cancer to neoadjuvant chemotherapy.
    Sciuto R; Pasqualoni R; Bergomi S; Petrilli G; Vici P; Belli F; Botti C; Mottolese M; Maini CL
    J Nucl Med; 2002 Jun; 43(6):745-51. PubMed ID: 12050317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioguided surgery using intravenous 99mTc sestamibi associated with breast magnetic resonance imaging for guidance of breast cancer resection.
    Duarte GM; dos Santos CC; Torresan RZ; Alvarenga M; Telles GH; Bianchessi ST; Caserta N; Segala SR; Lopes de Lima Mda C; de Camargo Etchebehere EC; Camargo EE
    Breast J; 2006; 12(3):202-7. PubMed ID: 16684316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammoscintigraphy with technetium-99m-sestamibi in suspected breast cancer.
    Villanueva-Meyer J; Leonard MH; Briscoe E; Cesani F; Ali SA; Rhoden S; Hove M; Cowan D
    J Nucl Med; 1996 Jun; 37(6):926-30. PubMed ID: 8683313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between uptake of Tc-99m sestaMIBI and prognostic factors of breast cancer.
    Cwikla JB; Buscombe JR; Kolasinska AD; Parbhoo SP; Thakrar DS; Hilson AJ
    Anticancer Res; 1999; 19(3B):2299-304. PubMed ID: 10472348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 99mTc-N-DBODC5, a new myocardial perfusion imaging agent with rapid liver clearance: comparison with 99mTc-sestamibi and 99mTc-tetrofosmin in rats.
    Hatada K; Riou LM; Ruiz M; Yamamichi Y; Duatti A; Lima RL; Goode AR; Watson DD; Beller GA; Glover DK
    J Nucl Med; 2004 Dec; 45(12):2095-101. PubMed ID: 15585487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue-specific effects on uptake of 99mTc-sestamibi by breast lesions: a targeted analysis of false scintigraphic diagnoses.
    Tiling R; Stephan K; Sommer H; Shabani N; Linke R; Hahn K
    J Nucl Med; 2004 Nov; 45(11):1822-8. PubMed ID: 15534050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scintimammographic detection of usual ductal breast hyperplasia with increased proliferation rate at risk for malignancy.
    Papantoniou V; Tsiouris S; Koutsikos J; Sotiropoulou M; Mainta E; Lazaris D; Valsamaki P; Melissinou M; Zerva C; Antsaklis A
    Nucl Med Commun; 2006 Nov; 27(11):911-7. PubMed ID: 17021432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography.
    Gommans GM; van der Zant FM; van Dongen A; Boer RO; Teule GJ; de Waard JW
    Eur J Surg Oncol; 2007 Feb; 33(1):23-7. PubMed ID: 17126524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limitations of craniocaudal thallium-201 and technetium-99m-sestamibi mammoscintigraphy.
    Maurer AH; Caroline DF; Jadali FJ; Manzone TA; Maier WP; Au FC; Schnall SF
    J Nucl Med; 1995 Sep; 36(9):1696-700. PubMed ID: 7658233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of 99mTc-methylene diphosphonate and 99mTc-pentavalent DMSA compared with 99mTc-sestamibi for palpable breast lesions.
    Massardo T; Alonso O; Kabasakal L; Llamas-Olier A; Shankar UR; Zhu H; Delgado L; González P; Mut F; Padhy AK
    J Nucl Med; 2002 Jul; 43(7):882-8. PubMed ID: 12097457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo detection of resistance to anthracycline based neoadjuvant chemotherapy in locally advanced and inflammatory breast cancer with technetium-99m sestamibi scintimammography.
    Mezi S; Primi F; Capoccetti F; Scopinaro F; Modesti M; Schillaci O
    Int J Oncol; 2003 Jun; 22(6):1233-40. PubMed ID: 12738988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incremental diagnostic value of quantitative analysis of double phase Tc-99m MIBI scintimammography for the detection of primary breast cancer additive to visual analysis.
    Kim SJ; Kim IJ; Bae YT; Kim YK; Kim DS
    Breast Cancer Res Treat; 2004 Jan; 83(2):129-38. PubMed ID: 14997043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography.
    Papantoniou V; Tsiouris S; Mainta E; Valotassiou V; Souvatzoglou M; Sotiropoulou M; Nakopoulou L; Lazaris D; Louvrou A; Melissinou M; Tzannetaki A; Pirmettis I; Koutsikos J; Zerva C
    Breast Cancer Res; 2005; 7(1):R33-45. PubMed ID: 15642168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing the uptake of 99mTc-sestamibi in breast tissue on molecular breast imaging.
    O'Connor MK; Hruska CB; Tran TD; Swanson T; Conners AL; Jones K; Rhodes DJ
    J Nucl Med Technol; 2015 Mar; 43(1):13-20. PubMed ID: 25613340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.